Assessment of the impact of FcγRIIIA single-nucleotide polymorphisms on the efficacy of IgG1 monoclonal antibodies in patients with advanced gastroesophageal adenocarcinoma.

ESMO Gastrointest Oncol · 2023 · PMC12836626 · PMID 41647730

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

showed a trendP = 0.07so close (0.05 < p ≤ 0.1)

The mOS was similar for all genotypes in the PANGEA cohort, while the non-PANGEA cohort showed a trend towards prolonged survival in the non-F/F subgroup (mOS 43.4 versus 23.1 months, P = 0.07; Figure 2 A-C; Table 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.